Williams & Connolly LLP is noted for its ability to defend clients facing class actions and government enforcement actions, representing major clients in the tech and pharmaceutical industries in government-led and business-to-business suits. The practice is headed jointly by John Schmidtlein, who has experience representing both defendants and plaintiffs in suits alleging monopolization, bid rigging and drug pricing, and Jonathan Pitt, who is noted for his work on matters tied to, inter alia, no poach agreements, price fixing and so-called pay-for-delay claims. Benjamin Greenblum is the practice’s key contact for antitrust matters arising out of Hatch-Waxman disputes, representing a number of high profile clients in the food and pharmaceutical sectors, while Carl Metz maintains a practice that covers defense of monopolization and unfair trade practices claims. All lawyers mentioned are in Washington DC.
Key clients
- Amazon
- CVS Health
- AstraZeneca
- University of Notre Dame
- Jazz Pharmaceuticals
- Celgene/Bristol Myers-Squibb
- Bank of America/Merrill Lynch
- The Washington Post
- Pfizer
- Southwest Mountain States Regional Council of Carpenters
Work highlights
- Acted as lead counsel for Google in antitrust enforcement actions brought by the US DOJ and various State Attorneys General accusing the company of maintaining an illegal monopoly over internet search and search advertising.
- Acted as lead trial counsel and co-lead counsel for Amazon in antitrust litigation filed by the FTC in the Western District of Washington.
- Acted as lead counsel for AstraZeneca against proposed antitrust class actions alleging the company entered into anticompetitive patent settlement agreements with generic drug manufacturers to protect its brand antipsychotic drug Seroquel XR.
Lawyers
Practice head
The lawyer(s) leading their teams.
John Schmidtlein, Jonathan Pitt